Twinlab Consolidated Holdings Inc TLCC

$0.00 0.00 (—)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
500
Avg volume
—
Day's range
$0.00 – $0.00
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements, skincare, and other natural products in the United States and internationally. The company offers vitamins, minerals, resveratrol, collagen, keratin, specialty supplements, and sports nutrition products under the Twinlab, Reserveage, and ResVitale brands; healthy aging and beau...

Show more

Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements, skincare, and other natural products in the United States and internationally. The company offers vitamins, minerals, resveratrol, collagen, keratin, specialty supplements, and sports nutrition products under the Twinlab, Reserveage, and ResVitale brands; healthy aging and beauty products under the Reserveage Nutrition and ResVitale brands; diet and energy products under the Metabolife; and a line of herbal teas under the Alvita brand. It also provides services between private label distributors and contract manufacturers under the NutraScience Labs brand name. The company sells its products in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, stick packs, whole herbs, sprays, and powders primarily through health and natural food stores, supermarkets, mass market retailers, specialty retailers, online retailers, and websites. Twinlab Consolidated Holdings, Inc. was founded in 1968 and is based in Weston, Florida.

Industry
Packaged Foods
Sector
Consumer Defensive
Phone
561 443 4301
Website
https://www.tchhome.com
Address
304 Indian Trace #438, Weston, United States

Latest news

No headlines yet.